Brief: Initiator Pharma Reports Positive Phase IIa Clinical Data For IPED2015 In Patients With Severe Erectile Dysfunction

Initiator Pharma A/S

05/12/2019 07:11

Dec 5 (Reuters) - Initiator Pharma A/S  INIT.TE :
    * INITIATOR PHARMA REPORTS POSITIVE PHASE IIA CLINICAL DATA
FOR
IPED2015 IN PATIENTS WITH SEVERE ERECTILE DYSFUNCTION
    * MOREOVER, NO OBSERVATIONS OF CRITICAL ADVERSE EVENTS WERE
RECORDED.
    * TODAY ANNOUNCED STATISTICALLY SIGNIFICANT RESULTS ON KEY
EFFICACY ENDPOINTS IN SEVERE ED PATIENTS AFTER A SINGLE
ADMINISTRATION OF IPED2015.
    * FURTHER ANALYSIS OF DATA AND REPORT WRITING HAS BEEN
INITIATED,
AND FINAL REPORT IS EXPECTED LATER IN Q1 OF 2020.
    * THERE HAS BEEN NO REPORTING OF CRITICAL SAFETY
OBSERVATIONS
WHICH IS IN LINE WITH PREVIOUSLY REPORTED RESULTS FROM PHASE I
TRIAL IN HEALTHY VOLUNTEERS

Source text for Eikon:  ID:nWkr2RS9PW 
Further company coverage:  INIT.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))